Ulcerative colitis: STRIDE-ing beyond symptoms with new standards
The landscape of ulcerative colitis has changed in the last two decades. Advancements in pharmacotherapeutics have heralded the introduction of new treatment options, with many agents in development. Better clinical outcomes are seen with tighter disease control, made possible with greater understan...
Saved in:
Main Authors: | Shu Wen Tay, Kevin Kim Jun Teh, Tiing-Leong Ang, Malcolm Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer – Medknow Publications
2024-02-01
|
Series: | Singapore Medical Journal |
Subjects: | |
Online Access: | https://journals.lww.com/10.11622/smedj.2021173 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Features of development and progression of colorectal cancer on a background of ulcerative colitis
by: I. L. Khalif, et al.
Published: (2012-02-01) -
Health benefits of algae and marine-derived bioactive metabolites for modulating ulcerative colitis symptoms
by: Najmeh Oliyaei, et al.
Published: (2025-02-01) -
Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01) -
Prognosis of unfavorable course of ulcerative colitis as indication for anticytokine therapy
by: A. Yu. Baranovsky, et al.
Published: (2012-06-01) -
Serum cytokines in ulcerative colitis of various clinical activity
by: Ye. A. Konovich, et al.
Published: (2014-10-01)